Fintech
Contakt World to Offer Vaccine Passport and Verification Platform To Employers, Events and Organizations, Including Customers of Recently Acquired HealthCheck App
HealthCheck app provides an ideal technology environment for combined symptom screening, vaccine passport and verification
- Contakt World intends to offer existing and new customers integrated tools for vaccine passport and verification.
- Vaccine passports critical as Delta variant of COVID-19 rages through U.S. and global populations, alongside
Pfizer Vaccine Losing Efficacy Faster Against Delta Variant
To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/8151/94332_VaccinePassportsContaktWorld.jpgOther Recent News from Contakt World:
1 The chart above is from Statista, originating from The Independent’s reporting:
https://www.statista.com/chart/25575/pfizer-astrazeneca-efficacy-loss/
To Learn More:
To receive investor updates from Contakt World Technologies Corp. (CSE: HELP), click here.
If you are an organization seeking daily health screening and future vaccine passports, schedule a demo of HealthCheck by clicking here.
About Contakt World
Contakt World (CSE: HELP) is a technology company developing and delivering SaaS solutions for the public and private sectors. The company integrates data collection and management, communications, advertising, and IOT devices – providing customers with a scalable ecosystem that makes sense of people, place, time, and space for the emerging “phygital” (blending physical and digital) world. Contakt World is committed to improving health equity and healthcare access while solving sector-specific business challenges. For more information, please visit https://contakt.world/.
Contakt World Contact
Zayn Kalyn
Interim CEO and Director
Direct: 778-938-3367The CSE has not reviewed, approved or disapproved the content of this news release.
Forward Looking Statements Disclaimer
This press release contains “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”), including, but not limited to, statements with respect to the future prospects of Contakt World. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “projects”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements, including statements respecting: Healthcheck’s integration into Contakt World’s offerings, business plan and growth strategy; Healthchecks’s prospects as a platform and service; Contakt World’s ability to scale and sell HealthCheck; Contakt World’s ability to deploy a successful vaccine passport; and Contakt World’s ability to leverage Healthcheck going forward. Although forward-looking statements contained in this press release are based upon what management of Contakt World believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The forward-looking statements may also be affected by risks and uncertainties in the business of Contakt World, including those described in the Company’s public filings available on www.SEDAR.com. Contakt World undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Canadian Securities Exchange (CSE) has not reviewed, approved or disapproved the content of this news release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/94332